Skip to main content
Erschienen in: Cancer Causes & Control 5/2010

01.05.2010 | Original paper

Prospective study of physical activity and risk of primary adenocarcinomas of the oesophagus and stomach in the EPIC (European Prospective Investigation into Cancer and nutrition) cohort

verfasst von: José María Huerta, Carmen Navarro, María-Dolores Chirlaque, María-José Tormo, Karen Steindorf, Genevieve Buckland, Fátima Carneiro, Nina Føns Johnsen, Kim Overvad, Jakob Stegger, Anne Tjønneland, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon, Sophie Morois, Heiner Boeing, Rudolf Kaaks, Sabine Rohrmann, Matthäus Vigl, Pagona Lagiou, Dimitrios Trichopoulos, Antonia Trichopoulou, H. Bas Bueno-de-Mesquita, Evelyn M. Monninkhof, Mattijs E. Numans, Petra H. Peeters, Amalia Mattiello, Valeria Pala, Domenico Palli, Rosario Tumino, Paolo Vineis, Antonio Agudo, Eva Ardanaz, Larraitz Arriola, Esther Molina-Montes, Laudina Rodríguez, Björn Lindkvist, Jonas Manjer, Roger Stenling, Eiliv Lund, Francesca L. Crowe, Timothy J. Key, Kay-Tee Khaw, Nicholas J. Wareham, Mazda Jenab, Teresa Norat, Dora Romaguera, Elio Riboli, Carlos A. González

Erschienen in: Cancer Causes & Control | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

To analyse the association between types of physical activity (occupational, recreational and household, vigorous and overall) and risk of primary oesophageal (OAC) or gastric adenocarcinoma (GAC).

Methods

From nine European countries, 420,449 participants were recruited between 1991 and 2000 and followed-up for a mean of 8.8 years to register incident GAC and OAC. Information on physical activity (PA), diet, lifestyle and health-related variables was obtained at baseline. Helicobacter pylori infection status was considered in a subset of 1,211 participants. Analyses were repeated by tumour site (cardia/non-cardia) and histological type (intestinal/diffuse).

Results

During the follow-up, 410 GAC and 80 OAC occurred. A lower risk of overall and non-cardia GAC was found for increasing levels of a PA index which combined occupational PA with weekly time spent in sports and cycling. The hazard ratio (HR) of GAC was 0.69, 95% CI: 0.50–0.94, for the comparison between active and inactive participants according to the PA index (HR = 0.44, 95% CI:0.26–0.74, for non-cardia GAC). No effect was found for cardia tumours or histological subtypes of GAC. PA of any kind was not associated with OAC.

Conclusions

Overall and distal (non-cardia) gastric tumours were inversely associated with time spent on cycling and sports and a total PA index. No association was found for any type of PA and risk of cardia cancers of the stomach.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Forman D, Burley VJ (2006) Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 20:633–649CrossRefPubMed Forman D, Burley VJ (2006) Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 20:633–649CrossRefPubMed
2.
Zurück zum Zitat Boyle P, Levin B (2009) World cancer report 2008. IARC, Lyon Boyle P, Levin B (2009) World cancer report 2008. IARC, Lyon
3.
Zurück zum Zitat Bertuccio P, Chatenoud L, Levi F et al (2009) Recent patterns in gastric cancer: a global overview. Int J Cancer 125:666–673CrossRefPubMed Bertuccio P, Chatenoud L, Levi F et al (2009) Recent patterns in gastric cancer: a global overview. Int J Cancer 125:666–673CrossRefPubMed
4.
Zurück zum Zitat Steevens J, Botterweck AA, Dirx MJ, van Den Brandt PA, Schouten LJ (2009) Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol Steevens J, Botterweck AA, Dirx MJ, van Den Brandt PA, Schouten LJ (2009) Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol
5.
Zurück zum Zitat Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS (2009) Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev 18:1945–1952CrossRefPubMed Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS (2009) Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev 18:1945–1952CrossRefPubMed
6.
Zurück zum Zitat World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington DC World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington DC
7.
Zurück zum Zitat Monninkhof EM, Elias SG, Vlems FA et al (2007) Physical activity and breast cancer: a systematic review. Epidemiology 18:137–157CrossRefPubMed Monninkhof EM, Elias SG, Vlems FA et al (2007) Physical activity and breast cancer: a systematic review. Epidemiology 18:137–157CrossRefPubMed
8.
Zurück zum Zitat Samad AK, Taylor RS, Marshall T, Chapman MA (2005) A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Dis 7:204–213CrossRefPubMed Samad AK, Taylor RS, Marshall T, Chapman MA (2005) A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Dis 7:204–213CrossRefPubMed
9.
Zurück zum Zitat Tardón A, Lee WJ, Delgado-Rodríguez M et al (2005) Leisure-time physical activity and lung cancer: a meta-analysis. Cancer Causes Control 16:389–397CrossRefPubMed Tardón A, Lee WJ, Delgado-Rodríguez M et al (2005) Leisure-time physical activity and lung cancer: a meta-analysis. Cancer Causes Control 16:389–397CrossRefPubMed
10.
Zurück zum Zitat Voskuil DW, Monninkhof EM, Elias SG, Vlems FA, van Leeuwen FE (2007) Physical activity and endometrial cancer risk, a systematic review of current evidence 1. Cancer Epidemiol Biomarkers Prev 16:639–648CrossRefPubMed Voskuil DW, Monninkhof EM, Elias SG, Vlems FA, van Leeuwen FE (2007) Physical activity and endometrial cancer risk, a systematic review of current evidence 1. Cancer Epidemiol Biomarkers Prev 16:639–648CrossRefPubMed
11.
Zurück zum Zitat Campbell PT, Sloan M, Kreiger N (2007) Physical activity and stomach cancer risk: the influence of intensity and timing during the lifetime. Eur J Cancer 43:593–600CrossRefPubMed Campbell PT, Sloan M, Kreiger N (2007) Physical activity and stomach cancer risk: the influence of intensity and timing during the lifetime. Eur J Cancer 43:593–600CrossRefPubMed
12.
Zurück zum Zitat Davey SG, Shipley MJ, Batty GD, Morris JN, Marmot M (2000) Physical activity and cause-specific mortality in the Whitehall study. Public Health 114:308–315CrossRef Davey SG, Shipley MJ, Batty GD, Morris JN, Marmot M (2000) Physical activity and cause-specific mortality in the Whitehall study. Public Health 114:308–315CrossRef
13.
Zurück zum Zitat Nomura AM, Stemmermann GN, Chyou PH (1995) Gastric cancer among the Japanese in Hawaii. Jpn J Cancer Res 86:916–923PubMed Nomura AM, Stemmermann GN, Chyou PH (1995) Gastric cancer among the Japanese in Hawaii. Jpn J Cancer Res 86:916–923PubMed
14.
Zurück zum Zitat Severson RK, Nomura AM, Grove JS, Stemmermann GN (1989) A prospective analysis of physical activity and cancer. Am J Epidemiol 130:522–529PubMed Severson RK, Nomura AM, Grove JS, Stemmermann GN (1989) A prospective analysis of physical activity and cancer. Am J Epidemiol 130:522–529PubMed
15.
Zurück zum Zitat Vigen C, Bernstein L, Wu AH (2006) Occupational physical activity and risk of adenocarcinomas of the esophagus and stomach. Int J Cancer 118:1004–1009CrossRefPubMed Vigen C, Bernstein L, Wu AH (2006) Occupational physical activity and risk of adenocarcinomas of the esophagus and stomach. Int J Cancer 118:1004–1009CrossRefPubMed
16.
Zurück zum Zitat Wannamethee SG, Shaper AG, Walker M (2001) Physical activity and risk of cancer in middle-aged men. Br J Cancer 85:1311–1316CrossRefPubMed Wannamethee SG, Shaper AG, Walker M (2001) Physical activity and risk of cancer in middle-aged men. Br J Cancer 85:1311–1316CrossRefPubMed
17.
Zurück zum Zitat Yun YH, Lim MK, Won YJ et al (2008) Dietary preference, physical activity, and cancer risk in men: national health insurance corporation study. BMC Cancer 8:366CrossRefPubMed Yun YH, Lim MK, Won YJ et al (2008) Dietary preference, physical activity, and cancer risk in men: national health insurance corporation study. BMC Cancer 8:366CrossRefPubMed
18.
Zurück zum Zitat Sjödahl K, Jia C, Vatten L, Nilsen T, Hveem K, Lagergren J (2008) Body mass and physical activity and risk of gastric cancer in a population-based cohort study in Norway. Cancer Epidemiol Biomarkers Prev 17:135–140CrossRefPubMed Sjödahl K, Jia C, Vatten L, Nilsen T, Hveem K, Lagergren J (2008) Body mass and physical activity and risk of gastric cancer in a population-based cohort study in Norway. Cancer Epidemiol Biomarkers Prev 17:135–140CrossRefPubMed
19.
Zurück zum Zitat Inoue M, Yamamoto S, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S (2008) Daily total physical activity level and total cancer risk in men and women: results from a large-scale population-based cohort study in Japan. Am J Epidemiol 168:391–403CrossRefPubMed Inoue M, Yamamoto S, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S (2008) Daily total physical activity level and total cancer risk in men and women: results from a large-scale population-based cohort study in Japan. Am J Epidemiol 168:391–403CrossRefPubMed
20.
Zurück zum Zitat Leitzmann MF, Koebnick C, Freedman ND et al (2009) Physical activity and esophageal and gastric carcinoma in a large prospective study. Am J Prev Med 36:112–119CrossRefPubMed Leitzmann MF, Koebnick C, Freedman ND et al (2009) Physical activity and esophageal and gastric carcinoma in a large prospective study. Am J Prev Med 36:112–119CrossRefPubMed
21.
Zurück zum Zitat Riboli E, Kaaks R (1997) The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26(Suppl 1):S6–S14CrossRefPubMed Riboli E, Kaaks R (1997) The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26(Suppl 1):S6–S14CrossRefPubMed
22.
Zurück zum Zitat Riboli E, Hunt KJ, Slimani N et al (2002) European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113–1124CrossRefPubMed Riboli E, Hunt KJ, Slimani N et al (2002) European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113–1124CrossRefPubMed
23.
Zurück zum Zitat Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498–S504CrossRefPubMed Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498–S504CrossRefPubMed
24.
Zurück zum Zitat Wareham NJ, Jakes RW, Rennie KL et al (2003) Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 6:407–413CrossRefPubMed Wareham NJ, Jakes RW, Rennie KL et al (2003) Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 6:407–413CrossRefPubMed
25.
Zurück zum Zitat World Health Organization (1990) International classification of diseases for oncology. Second Edition (ICD-O 2). WHO, Geneva World Health Organization (1990) International classification of diseases for oncology. Second Edition (ICD-O 2). WHO, Geneva
26.
Zurück zum Zitat Laurén P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49PubMed Laurén P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49PubMed
27.
Zurück zum Zitat Carneiro F, Moutinho C, Pera G et al (2007) Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST). Scand J Gastroenterol 42:618–627CrossRefPubMed Carneiro F, Moutinho C, Pera G et al (2007) Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST). Scand J Gastroenterol 42:618–627CrossRefPubMed
28.
Zurück zum Zitat Korn EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145:72–80PubMed Korn EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145:72–80PubMed
29.
Zurück zum Zitat Palli D, Masala G, Del GG et al (2007) CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 120:859–867CrossRefPubMed Palli D, Masala G, Del GG et al (2007) CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 120:859–867CrossRefPubMed
30.
Zurück zum Zitat von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 4:e296CrossRef von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 4:e296CrossRef
31.
32.
Zurück zum Zitat Friedenreich CM, Thune I (2001) A review of physical activity and prostate cancer risk. Cancer Causes Control 12:461–475CrossRefPubMed Friedenreich CM, Thune I (2001) A review of physical activity and prostate cancer risk. Cancer Causes Control 12:461–475CrossRefPubMed
33.
Zurück zum Zitat González CA, Pera G, Agudo A et al (2006) Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer 118:2559–2566CrossRefPubMed González CA, Pera G, Agudo A et al (2006) Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer 118:2559–2566CrossRefPubMed
34.
Zurück zum Zitat González CA, Jakszyn P, Pera G et al (2006) Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98:345–354PubMedCrossRef González CA, Jakszyn P, Pera G et al (2006) Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98:345–354PubMedCrossRef
35.
Zurück zum Zitat Kubo A, Corley DA (2006) Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 15:872–878CrossRefPubMed Kubo A, Corley DA (2006) Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 15:872–878CrossRefPubMed
36.
Zurück zum Zitat Friedenreich CM, Orenstein MR (2002) Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 132:3456S–3464SPubMed Friedenreich CM, Orenstein MR (2002) Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 132:3456S–3464SPubMed
38.
Zurück zum Zitat Pedersen BK, Hoffman-Goetz L (2000) Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 80:1055–1081PubMed Pedersen BK, Hoffman-Goetz L (2000) Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 80:1055–1081PubMed
39.
Zurück zum Zitat Yuasa Y, Nagasaki H, Akiyama Y et al. (2008) DNA methylation status is inversely correlated with green tea intake and physical activity in gastric cancer patients. Int J Cancer Yuasa Y, Nagasaki H, Akiyama Y et al. (2008) DNA methylation status is inversely correlated with green tea intake and physical activity in gastric cancer patients. Int J Cancer
40.
Zurück zum Zitat Wanajo A, Sasaki A, Nagasaki H et al (2008) Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer. Gastroenterology 135:580–590CrossRefPubMed Wanajo A, Sasaki A, Nagasaki H et al (2008) Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer. Gastroenterology 135:580–590CrossRefPubMed
41.
Zurück zum Zitat Haftenberger M, Schuit AJ, Tormo MJ et al (2002) Physical activity of subjects aged 50–64 years involved in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 5:1163–1176CrossRefPubMed Haftenberger M, Schuit AJ, Tormo MJ et al (2002) Physical activity of subjects aged 50–64 years involved in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 5:1163–1176CrossRefPubMed
42.
Zurück zum Zitat Webb PM, Crabtree JE, Forman D (1999) Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. The Eurogast Study Group. Gastroenterology 116:269–276CrossRefPubMed Webb PM, Crabtree JE, Forman D (1999) Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. The Eurogast Study Group. Gastroenterology 116:269–276CrossRefPubMed
Metadaten
Titel
Prospective study of physical activity and risk of primary adenocarcinomas of the oesophagus and stomach in the EPIC (European Prospective Investigation into Cancer and nutrition) cohort
verfasst von
José María Huerta
Carmen Navarro
María-Dolores Chirlaque
María-José Tormo
Karen Steindorf
Genevieve Buckland
Fátima Carneiro
Nina Føns Johnsen
Kim Overvad
Jakob Stegger
Anne Tjønneland
Marie-Christine Boutron-Ruault
Françoise Clavel-Chapelon
Sophie Morois
Heiner Boeing
Rudolf Kaaks
Sabine Rohrmann
Matthäus Vigl
Pagona Lagiou
Dimitrios Trichopoulos
Antonia Trichopoulou
H. Bas Bueno-de-Mesquita
Evelyn M. Monninkhof
Mattijs E. Numans
Petra H. Peeters
Amalia Mattiello
Valeria Pala
Domenico Palli
Rosario Tumino
Paolo Vineis
Antonio Agudo
Eva Ardanaz
Larraitz Arriola
Esther Molina-Montes
Laudina Rodríguez
Björn Lindkvist
Jonas Manjer
Roger Stenling
Eiliv Lund
Francesca L. Crowe
Timothy J. Key
Kay-Tee Khaw
Nicholas J. Wareham
Mazda Jenab
Teresa Norat
Dora Romaguera
Elio Riboli
Carlos A. González
Publikationsdatum
01.05.2010
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 5/2010
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9493-x

Weitere Artikel der Ausgabe 5/2010

Cancer Causes & Control 5/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.